KARINA KLAUDIA LISSAK

Dr. KARINA KLAUDIA LISSAK

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
AKAgata Konopka
Agata Konopka
ZSZuzanna Szczepaniak
Zuzanna Szczepaniak
NWNatalia Wdowiak
Natalia Wdowiak
KLKARINA KLAUDIA LISSAK
KARINA KLAUDIA LISSAK
MKMałgorzata Komarów
Małgorzata Komarów
JKJakub Kalisiak
Jakub Kalisiak
Introduction: TORCH syndrome refers to a group of symptoms caused by congenital infections with teratogenic pathogens, including Toxoplasma gondii, Varicella, Treponema pallidum, Parvovirus B19, Rubella, Cytomegalovirus (CMV), and Herpes simplex virus (HSV). It can also encompass infections like HIV, Zika virus (ZIKV), hepatitis B, and SARS-CoV-2. These pathogens can pass through the placenta, overcoming various placental barriers. Infections during pregnancy can result in severe consequences for both the fetus and the mother. Common symptoms in newborns include low birth weight, rashes, hepatosplenomegaly, cardiac anomalies, jaundice, chorioretinitis, and microcephaly, with 2% to 3% of congenital anomalies attributed to perinatal infections. The incidence of these infections varies globally. Purpose of the work: This study aims to review and characterize TORCH syndrome and the prevention of TORCH infections. Materials and methods: A comprehensive analysis of research papers available on PubMed, Google Scholar, Web of Science, Embase and Scopus was undertaken using the searchterms encompassing the following keywords: TORCH syndrome / infections during pregnancy / perinatal infections / Toxoplasmosis / Rubella / CMV infection / Herpes Simplex Virus infection / Parvovirus B19 / Treponema pallidum / vaccinations before and during pregnancy / maternal nutrition. Results: TORCH syndrome is a significant issue causing congenital diseases, premature births, and intrauterine deaths, impacting babies throughout their lives. Most complications can be prevented with proper prophylaxis and early treatment. Increasing awareness and providing education for women from preconception through the early postnatal period is essential. Addressing TORCH syndrome remains a major medical challenge, but improving management offers hope for better outcomes.

16 September 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
ZSZuzanna Szczepaniak
Zuzanna Szczepaniak
AKAgata Konopka
Agata Konopka
NWNatalia Wdowiak
Natalia Wdowiak
KLKARINA KLAUDIA LISSAK
KARINA KLAUDIA LISSAK
MKMałgorzata Komarów
Małgorzata Komarów
JKJakub Kalisiak
Jakub Kalisiak
Introduction: Congenital adrenal hyperplasia (CAH) is a group of diseases in which genetic defects occur that disturb the synthesis of cortisol. The most common variant of CAH (95%-99%) is caused by 21-hydroxylase deficiency as a result of mutations in the CYP21A2 gene and is one of the most common monogenic diseases. CAH is characterized by androgen overproduction along with variable degrees of cortisol and aldosterone deficiency. Age at diagnosis can provide some information about the underlying mutations, with those diagnosed at birth/early infancy being at greater risk of developing serious enzyme defects. Classic and non-classical forms of this disorder have been described in the literature. CAH diagnosis is based on the clinical presentation, hormonal panel, Adrenocorticotropic Hormone (ACTH) stimulation test, and genetic testing. The main goals of treatment for congenital adrenal hyperplasia are glucocorticoid/mineralcorticoid supplementation, control of high adrenal androgen levels, fertility control, genetic counseling, and optimization of patients’ quality of life. Purpose of the work: This study aims to review and characterize the clinical and pathophysiological aspects of congenital adrenal hyperplasia. Materials and methods: A comprehensive analysis of research papers available on PubMed, Google Scholar, Web of Science, Embase and Scopus was undertaken using the searchterms encompassing the following keywords: congenital adrenal hyperplasia, 21-hydroxylase deficiency, CYP21A2 Results: Congenital adrenal hyperplasia is a heterogeneous group of genetic disorders that can lead to serious and even fatal complications in the form of adrenal crisis. Therefore, screening tests and early diagnosis are crucial and can save the lives of newborns. Treatment should be individualized and allow patients to achieve normal growth, sexual development, fertility and a better quality of life.

29 September 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
KLKARINA KLAUDIA LISSAK
KARINA KLAUDIA LISSAK
ZSZuzanna Szczepaniak
Zuzanna Szczepaniak
AKAgata Konopka
Agata Konopka
NWNatalia Wdowiak
Natalia Wdowiak
MCMartyna Choinka
Martyna Choinka
BOBartłomiej Orzeł
Bartłomiej Orzeł
Uveal melanoma (UM) is a serious condition requiring immediate medical attention. It is the most common primary intraocular cancer in adults, with an incidence of around 5.2 cases per million people annually. Nearly half of UM patients develop metastatic disease, most often affecting the liver. UM refers to any malignant tumor arising from melanocytes in the uveal tract, which includes the iris, ciliary body, and choroid. Treatment options for UM depend on several factors, including tumor size, location, and the patient's overall health. These options may include radiation therapy, surgery, laser treatments, targeted therapies, and immunotherapy. UM is often described as an immune-privileged tumor, with a distinct immune profile compared to cutaneous melanoma (CM). This article aims to highlight the unique characteristics and challenges associated with this rare form of melanoma. By providing detailed information, the article seeks to enhance understanding and management of this rare form of melanoma.

7 August 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
BSBartosz Siudek
Bartosz Siudek
ODOlgierd Dróżdż
Olgierd Dróżdż
WBWiktoria Bińczyk
Wiktoria Bińczyk
KLKARINA KLAUDIA LISSAK
KARINA KLAUDIA LISSAK
BNBianka Nowińska
Bianka Nowińska
AWAnna Wiśniewska
Anna Wiśniewska
Diabetes mellitus (DM) encompasses a spectrum of metabolic disorders characterized by hyperglycemia due to defects in insulin secretion, action, or both. Type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) are the most prevalent forms, whereas Maturity-Onset Diabetes of the Young (MODY) represents a monogenic subtype, often misdiagnosed due to its phenotypic overlap. This case study highlights a 26-year-old male initially diagnosed with T1DM at age 12, managed with insulin therapy. Upon admission, despite stable glycemic control and preserved C-peptide secretion, genetic testing revealed MODY 2 due to a variant in the GCK gene. Unlike T1DM and T2DM, MODY 2 is characterized by mild, persistent hyperglycemia with a low risk of complications, emphasizing the importance of genetic diagnosis for tailored management and family counseling. This case underscores the critical role of genetic evaluation in accurately diagnosing and managing atypical diabetes presentations.

11 September 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
MCMartyna Choinka
Martyna Choinka
MKMałgorzata Komarów
Małgorzata Komarów
NWNatalia Wdowiak
Natalia Wdowiak
KLKARINA KLAUDIA LISSAK
KARINA KLAUDIA LISSAK
ZSZuzanna Szczepaniak
Zuzanna Szczepaniak
DKDominika Karasińska
Dominika Karasińska
Atopic dermatitis is a long-term inflammatory skin disease caused by factors such as skin barrier dysfunction and immune system dysregulation . Currently, the first-line treatment for atopic dermatitis involves the use of topical glucocorticosteroids; however, this treatment is associated with many side effects. Therefore the need of finding new methods of treatment arises. Objective: The objective of this study is to gather and analyze literature on new methods of treating atopic dermatitis. Materials and methods: The review was based on the analysis of materials collected in the database, PubMed, Google Scholar, Web of Science, Embaseand, Scopus, books and other scientific articles.

26 August 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
KLKARINA KLAUDIA LISSAK
KARINA KLAUDIA LISSAK
BNBianka Nowińska
Bianka Nowińska
WBWiktoria Bińczyk
Wiktoria Bińczyk
ODOlgierd Dróżdż
Olgierd Dróżdż
BSBartosz Siudek
Bartosz Siudek
KWKlaudia Włodarczyk
Klaudia Włodarczyk
Engaging in regular physical activity (PA) is crucial for managing type 1 diabetes (T1D) effectively. PA helps reduce the risk of cardiovascular disease (CVD), lower total daily insulin requirements, improve endothelial function, enhance muscular strength, and boost psychological well-being and quality of life. However, individuals with T1D tend to engage in PA less frequently than their healthy peers due to various barriers, with the fear of hypoglycemia (FOH) being a significant factor that impacts quality of life and diabetes outcomes. Understanding these barriers can increase awareness, improve comprehension, and enhance better support from non-diabetology specialists. This article aims to review the current literature on the primary limitations to regular PA, including continuous glucose management (CGM), in individuals with T1D. Additionally, we explore the impact of various types of PA on blood glucose management and overall well-being.